Issue 37 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

23

No.

37

September 26, 1997Sep 26, 1997

Free

DOWNLOAD THE PDF

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

Weinstein Applauds Investigation Report

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

Recent Issues

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026